These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 27302927)

  • 1. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
    Niyazi M; Pitea A; Mittelbronn M; Steinbach J; Sticht C; Zehentmayr F; Piehlmaier D; Zitzelsberger H; Ganswindt U; Rödel C; Lauber K; Belka C; Unger K
    Oncotarget; 2016 Jul; 7(29):45764-45775. PubMed ID: 27302927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
    Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
    Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients.
    Yuan GQ; Wei NL; Mu LY; Wang XQ; Zhang YN; Zhou WN; Pan YW
    Cancer Biomark; 2017 Dec; 20(4):443-452. PubMed ID: 28869437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long non-coding RNA signature in glioblastoma multiforme predicts survival.
    Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK
    Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.
    Sana J; Radova L; Lakomy R; Kren L; Fadrus P; Smrcka M; Besse A; Nekvindova J; Hermanova M; Jancalek R; Svoboda M; Hajduch M; Slampa P; Vyzula R; Slaby O
    Carcinogenesis; 2014 Dec; 35(12):2756-62. PubMed ID: 25322872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
    Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
    Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA expression patterns predict survival in glioblastoma.
    Niyazi M; Zehentmayr F; Niemöller OM; Eigenbrod S; Kretzschmar H; Schulze-Osthoff K; Tonn JC; Atkinson M; Mörtl S; Belka C
    Radiat Oncol; 2011 Nov; 6():153. PubMed ID: 22074483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
    PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
    Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A robust two-gene signature for glioblastoma survival prediction.
    Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
    J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
    Gong Z; Hong F; Wang H; Zhang X; Chen J
    BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients.
    Mock A; Geisenberger C; Orlik C; Warta R; Schwager C; Jungk C; Dutruel C; Geiselhart L; Weichenhan D; Zucknick M; Nied AK; Friauf S; Exner J; Capper D; Hartmann C; Lahrmann B; Grabe N; Debus J; von Deimling A; Popanda O; Plass C; Unterberg A; Abdollahi A; Schmezer P; Herold-Mende C
    Int J Cancer; 2016 Jul; 139(2):424-32. PubMed ID: 26934681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identify signature regulatory network for glioblastoma prognosis by integrative mRNA and miRNA co-expression analysis.
    Bing ZT; Yang GH; Xiong J; Guo L; Yang L
    IET Syst Biol; 2016 Dec; 10(6):244-251. PubMed ID: 27879479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
    Fatai AA; Gamieldien J
    BMC Cancer; 2018 Apr; 18(1):377. PubMed ID: 29614978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 4-gene panel predicting the survival of patients with glioblastoma.
    Guo XX; Su J; He XF
    J Cell Biochem; 2019 Sep; 120(9):16037-16043. PubMed ID: 31081973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated mRNA and microRNA expression signature for glioblastoma multiforme prognosis.
    Xiong J; Bing Z; Su Y; Deng D; Peng X
    PLoS One; 2014; 9(5):e98419. PubMed ID: 24871302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
    Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
    Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients.
    Qiu S; Lin S; Hu D; Feng Y; Tan Y; Peng Y
    J Transl Med; 2013 Jan; 11():10. PubMed ID: 23302469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.